Corporate Strategy for a Biotech Company with a Diversified Portfolio

Publications
Category:
Published on:
April 1, 2020
Written by:
Joris Pezzini

When our client, a leader in the biopharmaceuticals space, needed support to assess their company’s competitive position and determine areas of growth and focus, the Alira Health team developed an in-depth scientific and commercial assessment covering the biopharma industry. See how this work focused our client on the most critical areas, helping them to marshall their resources and move forward with confidence.

For more information, please contact Joris Pezzini.

For more information about Alira Health’s Management Consulting services

Learn more

Related news

Publications June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
Data Specialist MedTech Pharma
News May 11, 2022
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
MedTech Patient Engagement Pharma
News April 5, 2022
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Clinical MedTech Patient Engagement Pharma Regulatory Research & Development
Publications March 31, 2022
The FDA’s Project Orbis Can Speed up the Delivery of Your New Oncology Drug to Global Markets
Are you developing an oncology drug? Project Orbis, a program coordinated by the U.S. Food and Drug Administration (FDA), allows you to register your product in several countries with(...)
Pharma Regulatory
Events March 4, 2022
Bio Europe Spring 2022
Meet us at Bio Europe Spring 2022. Connect with us to learn how Alira Health can help accelerate innovation and deliver tomorrow’s standard of care.
Pharma
Events February 14, 2022
Conferenza Nazionale Sulla Farmaceutica
We are thrilled to sponsor and attend Conferenza Nazionale Sulla Farmaceutica 2022 in Catania, Italy 
Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
M&A MedTech Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.